Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Editor’s Choice Award: Best Nootropics & Brain Pills 2014
  • USA - English


News provided by

Brain Pill Reviews

Jul 31, 2014, 08:00 ET

Share this article

Share toX

Share this article

Share toX

Brain Pill Reviews' 2014 Editor's Choice Awards for Brain Enhancement
Brain Pill Reviews' 2014 Editor's Choice Awards for Brain Enhancement

"After the scores were tallied, it seems that the mighty crown has once again fallen short of Neuroprime’s reach as it was handed to now two-time consecutive recipient of the award, NITROvit."

Post this

New York, NY (PRWEB) July 31, 2014 -- With Lucy, a movie about a brain enhancing drug, having hit cinemas nationwide just last week, the internet will no doubt be abuzz with Google searches for a similar substance allowing people the full 100% use of their brains. While this might seem like Hollywood fantasy, there are in fact brain pills, or ‘nootropics’, that do offer increased focus, memory retention and recall, mental acuity, and the overall optimization of brain performance. As these pills become increasingly mainstream every day, it is no surprise that they are fast-becoming as common as coffee in the pantry in the average American workplace.

Hollywood’s nootropic-fueled Lucy is nothing new, as 2011 saw a similar movie, ‘Limitless', hitting the silver screen. Both movies featured a brain enhancing drug that might be finally realized today with the modern nootropic brain pill. For many businesses, having a team on “brain steroids” creates what could be analogous to a workplace completely optimized for productivity, where every executive can potentially become a big-hitting superstar.

On the frontlines of these developments are a few nonprofit organizations run by diehard nootropic experts that test and review products with the ultimate goal of identifying the very best brain pill available out there. One such group, BrainPillReviews.com, has been biannually accrediting companies with their most prestigious Editor’s Choice Award for Brain Enhancement.

In a surprising turn of events, Neuro Laboratories’ NITROvit, dubbed the Advanced Cognitive Nootropic, has once again stolen Editor’s Choice Award from competitor Mind Nutrition's Neuroprime.

Martin Brison, Editor of BrainPillReviews.com reveals the results, “From over 2,800 available cognitive enhancing supplements on the market, NITROvit, Neuroprime, and Biohack Pure were all hoping to get their hands on the prestigious award. Those following us online would know that this year the stakes were even higher, as both NITROvit and Neuroprime had also been 2013’s finalists. After the scores were tallied, it seems that the mighty crown has once again fallen short of Neuroprime’s reach as it was handed to now two-time consecutive recipient of the award, NITROvit.”

The finalists were compared in a variety of categories, which included their short- and long-term effectiveness, quality of ingredients, community efforts in educating the ever-growing market, and overall value for money.

Brison explained, “While all three products performed exceptionally well, it is in long-term effects where NITROvit soared above the rest. We found NITROvit showed increasingly positive results with each passing month, as if the effects compounded. This was also confirmed by our reader’s reviews. That aside, NITROvit’s ingredients also suggested qualities that allowed for efficient fat loss, increased libido, and even showed efficacy as a quit smoking pill.”

NITROvit is the brainchild of Neuro Laboratories’ CEO and founder Archie Marks, a lifetime sufferer of ADD (Attention Deficit Disorder). Marks’ own fight against ADD and the passionate 8 years invested in bringing the final formula and product to fruition is what makes NITROvit as successful as it is today. In its current position, NITROvit’s clients aren’t just add sufferers, however, and include entrepreneurs, CEOs, medical practitioners, engineers, athletes and even members of the US military.

In 2013 alone, NITROvit had been recipient of 7 Editor’s Choice Awards for Brain Enhancement, and it seems as though this year may certainly be a repeat success.

Brison commented, “In today’s increasingly competitive work environment, the evolutionary theory ‘survival of the fittest’ cannot be expressed more strongly. While in the past, the definition of ‘fit’ might have changed many times over as we as a race evolved from hunters to farmers to the modern man, today’s societal definition of ‘fit’ demands us to perform at our absolute mental peak. What has long been the stuff of science fiction is to many people fast-becoming an everyday reality. If we are trying to get that promotion at work, striving to get on top of our hectic schedules, or are serious about taking our businesses above and beyond, brain enhancement through the use of nootropic supplements will allow us to reach that next level. The possibilities are endless.”

Click here to discover in full the benefits of NITROvit and its ingredients – recipient of 8 Editor’s and 5 Reader’s Choice Awards for Brain Enhancement, including the Brain Pill Reviews’ Editor’s Choice Award 2014.

To read about Martin Brison’s review on NITROvit and similar brain enhancing supplements, check out Brain Pill Reviews’ official website.

Martin Brison, Brain Pill Reviews, +1 (914) 587-7771, [email protected]

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.